Impact of COVID-19 and system recovery in delivering healthcare to people with multiple sclerosis: a population-based Study
Neurological Sciences · 2023
DOI: 10.1007/s10072-023-07052-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurological Sciences, 2023. Verfasst von Giuseppina Affinito und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, University of Naples Federico II, Via Sergio Pansini 5, 80131, Naples, Italy. Hauptthemen laut MEDLINE: Multiple Sclerosis, COVID-19. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Regione Campania, Università degli Studi di Napoli Federico II.
Abstract (Originalsprache)
Background
COVID-19 pandemic has affected the management of multiple sclerosis (MS).
Objective
To explore the impact of COVID-19 on healthcare delivery to people with MS and the subsequent recovery of the system.
Methods
In this population-based study in the Campania Region (Italy), we included people with MS across pre-COVID-19, lockdown, pre-vaccination, and vaccination periods. Differences in continuous outcomes between periods were explored using linear mixed models (annualized hospitalization rate (AHR) and adherence measured as medication possession ratio (MPR)). Differences in disease-modifying treatment (DMT) prescription rates (first DMT prescription, any DMT switch, switch from platform to highly effective DMT, and combination of first DMT prescription and any DMT switch) were assessed using an interrupted time series design.
Results
Compared with pre-COVID-19, AHR decreased during the lockdown (Coeff = 0.64;95%CI = -0.69, -0.59; p < 0.01), and remained lower during pre-vaccination and vaccination periods. Adherence decreased during pre-vaccination (Coeff = -0.04;95%CI = -0.05, -0.03; p < 0.01) and vaccination periods (Coeff = -0.07;95%CI = -0.08, -0.07; p < 0.01). After the lockdown, there was an increase in any DMT switch (IRR 2.05 95%CI 1.38,3.05; p < 0.01), in switch from platform to highly effective DMTs (IRR 4.45;95%CI 2.48,8.26; p < 0.01) and in first DMT prescriptions (IRR 2.48;95%CI 1.64,3.74; p < 0.01).
Conclusions
DMT prescriptions quickly returned to pre-pandemic levels, reflecting good health system recovery. However, adherence has remained lower than the past, as from suboptimal care. Assessing long-term COVID-19 impact on MS healthcare is warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Public Health, University of Naples Federico II, Via Sergio Pansini 5, 80131, Naples, Italy.
- Drug Policy and Devices Unit, Regione Campania Health Department, Naples, Italy.
- Regional Healthcare Society (So.Re.Sa), Naples, Italy.
- Innovation and Data Analytics (So.Re.Sa), Naples, Italy.
- Department of Neuroscience, Reproductive Sciences and Odontostomatology, Federico II University of Naples, Naples, Italy.
- Multiple Sclerosis Unit, Policlinico Federico II University Hospital, Naples, Italy.
Förderung
- Regione Campania
- Università degli Studi di Napoli Federico II
Zitieren
APA
Affinito, G., Trama, U., Palumbo, L., Fumo, M. G., Giordana, R., Di Gennaro, M., Triassi, M., Lanzillo, R., Morra, V. B., Palladino, R., & Moccia, M. (2023). Impact of COVID-19 and system recovery in delivering healthcare to people with multiple sclerosis: a population-based Study. Neurological Sciences. https://doi.org/10.1007/s10072-023-07052-9
Vancouver
Affinito G, Trama U, Palumbo L, Fumo MG, Giordana R, Di Gennaro M, et al. Impact of COVID-19 and system recovery in delivering healthcare to people with multiple sclerosis: a population-based Study. Neurological Sciences. 2023. doi:10.1007/s10072-023-07052-9
BibTeX
@article{Affinito2023,
author = {Affinito, Giuseppina and Trama, Ugo and Palumbo, Laura and Fumo, Maria Grazia and Giordana, Roberta and Di Gennaro, Massimo and Triassi, Maria and Lanzillo, Roberta and Morra, Vincenzo Brescia and Palladino, Raffaele and Moccia, Marcello},
title = {Impact of COVID-19 and system recovery in delivering healthcare to people with multiple sclerosis: a population-based Study},
journal = {Neurological Sciences},
year = {2023},
doi = {10.1007/s10072-023-07052-9}
}
EUVIMED